SCHEMBL17786902

SCHEMBL17786902

COCc1nn(Cc2cnc(Cl)nc2)cc1C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 19/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17786852 0.82 KLKB1 (0.57) KLKB1
SCHEMBL17786838 0.82 KLKB1 (0.47) KLKB1
SCHEMBL369754 0.81 KLKB1 (0.52) KLKB1
SCHEMBL31352716 0.81 KLKB1 (0.52) KLKB1
SCHEMBL17785314 0.81 KLKB1 (0.65) KLKB1
SCHEMBL30739019 0.80 KLKB1 (0.52) KLKB1
SCHEMBL17786840 0.77 KLKB1 (0.66) KLKB1
SCHEMBL17787181 0.76 LMNA (0.38) KLKB1
SCHEMBL17785303 0.75 KLKB1 (0.58) KLKB1
SCHEMBL17784845 0.75 KLKB1 (0.78) KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016083816-A1 N-((HETEROARYLMETHYL)-HETEROARYL-CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2016-06-02 — — WO disclosed
Send feedback